**Core Concept:**
Chang staging is a staging system used in pathology for assessing the extent of renal cell carcinoma (RCC) based on the number of tumor nodules and involvement of the renal vein, inferior vena cava, and lymph nodes. This staging system helps predict prognosis and guide treatment decisions.

**Why the Correct Answer is Right:**
Chang staging is based on the TNM classification system (Tumor, Node, Metastasis) and takes into account the following factors:
1. Number of primary tumor nodules: Single tumor (T1), multiple tumor nodules (T2-T4)
2. Renal vein involvement: No involvement (T3a), involvement of the renal vein (T3b), or involvement of the inferior vena cava (T4)
3. Lymph node involvement: No involvement (N0), involvement of the renal hilum (N1), or involvement of the pelvic or inguinal lymph nodes (N2)

By considering these factors, the stage can range from I (T1N0M0) to IV (T4N2M1). For example, a patient with a single tumor (T1), renal vein involvement (T3b), and no lymph node involvement (N0) would be classified as T3bN0M0.

**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because it does not consider renal vein involvement.
B. This option is incorrect because it does not consider lymph node involvement.
C. This option is incorrect because it does not consider the number of tumor nodules.
D. This option is incorrect because it does not consider renal vein involvement or lymph node involvement.

**Clinical Pearl:**
Understanding Chang staging helps in predicting prognosis and guiding treatment decisions for patients with renal cell carcinoma. Proper staging allows oncologists to choose the most appropriate therapy, such as surgery, radiotherapy, or targeted therapy, and monitor patient follow-up. In summary, Chang staging is crucial for optimizing patient care and outcomes in renal cell carcinoma management.